We should also have one for Canadian scientists in US. Stronger together regardless of borders. You know, the way it was before all this 51st state rhetoric. For the record, I love my American colleagues (that’s why I moved here) and think the current situation is an insult to us all.
Posts by Russ at UF
Absolutely beautiful work.
Thanks to @droch.bsky.social for correction - this should be Novo Nordisk not Roche
Thanks Julien. I questioned this after I hit send and was going to try to edit.
But I think your statement only applies if academia generates a compound because a process or pathway cannot be patented and any returns on compound go to university not NIH. I was thinking of what happens with Roche in Denmark but I am not versed in roadblocks here in US
From 2010 to 2016 (latest data I have ), NIH research contributed to EVERY drug approved by the FDA
Begging the question of why it is not mandated that a return of a percentage of profits on said drugs go back to fund NIH research.
Attention mitochondriacs! Mitochondrial supercomplexes by cryo-electron tomography. How can you not be blown away by how beautiful this is? Fascinating that ATP synthase is largely organized as dimers since this is one of the putative configurations of mPT pore. www.science.org/doi/10.1126/...
Congratulations Kevin!
I wonder how specific this may be to ALS? Aging also causes Tdp43 dysfunction (risk of ALS increases w age) www.nature.com/articles/s42... so perhaps this is more about importance of CoxIV to motoneuron survival than ALS per se?
Yet another report on the economic value of NIH investments The indiscriminate and large cuts are illogical and harmful I am angry www.forbes.com/sites/michae...
Please congratulate Casper and rest of your team for me!
New article alert from our group! If you have ever wondered what circulating factors associate with extremes of physical function in advanced age in humans, this provides some insights and raises plenty of questions: pubmed.ncbi.nlm.nih.gov/40059508/
... gait speed. Still better than anything molecular biomarkers can provide. Our commentary (with @regula-furrer.bsky.social @biozentrum.unibas.ch @unibas.ch) out now in NPJ Aging:
doi.org/10.1038/s415...
3/3
Our new review on longitudinal body comp in lung cancer is now in print!
journals.physiology.org/doi/full/10....
Just drop me a line, Vincent! Gilles knows how to reach me.
Scientists are now organizing events, called Stand Up for Science, on 7 March in Washington, D.C., and state capitals.
So far, they have attracted more than 100 volunteers from some 30 states who are hoping to rally support for research as a public good. scim.ag/4328LAD
A two-and-a-half-year-old girl shows no signs of a rare genetic disorder, after becoming the first person to be treated for the motor-neuron condition while in the womb.
https://go.nature.com/41a7Zzj
@DrJimmyBagley and I wrote this while he was fighting (and beating!) cancer. Grateful for him as my colleague and friend. “A primer on global molecular responses to exercise in skeletal muscle: Omics in focus”. Cutting edge! @JSHS_MedHealth #myoblue www.sciencedirect.com/science/arti...
We should try to partner with MoTrPAc to get comparator data on younger participants. Just a thought.
Sounds like a plan! I think an important component will be to address heterogeneity. My sense is that some will be responsive and others not so much.
It is this period when preservation of oxphos might become the cause of greater voluntary exercise rather than the result. Let’s call it a hypothesis 😊
Thanks for the very thoughtful reply, Gilles! I have no issue about exercise increasing oxphos except to make the point that I am not aware of any data addressing those >75 y, a time when the anabolic response to strength training is lost. pubmed.ncbi.nlm.nih.gov/18448613/
When studying mitochondria, it is essential to consider the impact of physical activity. Some findings attributed to 'aging' might actually be the result of decades of physical inactivity. ⬇️
www.cell.com/cell-reports...
Great work Gilles and team! To what degree do you think those who remain active with aging do so because they maintain mitochondrial oxphos capacity, rather than maintained oxphos being the outcome of being active?